Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate Cancer

1 Aug 2016

Abstract excerpt

Rapid advances in the discovery of long noncoding RNAs (lncRNAs) have identified lineage- and cancer-specific biomarkers that may be relevant in the clinical management of prostate cancer (PCa). Here we assembled and analyzed a large RNA-seq dataset, from 585 patient samples, including benign prostate tissue and both localized and metastatic PCa to discover and validate differentially expressed genes associated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Cancer-related molecular mechanisms research
Share to Prostate Cancer Treatment and Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27566105
DOI: 10.1016/j.neo.2016.07.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate CancerPMID 27566105Read ↗

Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progressionSemantic proximity Read ↗

The Transcriptomic Landscape of Prostate Cancer Development and Progression: An Integrative AnalysisSemantic proximity Read ↗

Unveiling novel double-negative prostate cancer subtypes through single-cell RNA sequencing analysisSemantic proximity Read ↗

Unveiling the NEFH+ malignant cell subtype: Insights from single-cell RNA sequencing in prostate cancer progression and tumor microenvironment interactionsSemantic proximity Read ↗

Single-cell sequencing analysis revealed that NEAT1 was a potential biomarker and therapeutic target of prostate cancerSemantic proximity Read ↗

Integrated analysis of single-cell and bulk transcriptomes uncovers clinically relevant molecular subtypes in human prostate cancerSemantic proximity Read ↗

Transcriptomics Signature from Next-Generation Sequencing Data Reveals New Transcriptomic Biomarkers Related to Prostate CancerSemantic proximity Read ↗

Integrated analysis of single-cell and bulk transcriptomics develops a robust neuroendocrine cell-intrinsic signature to predict prostate cancer progressionSemantic proximity Read ↗

Unveiling Novel Double-Negative Prostate Cancer Subtypes Through Single-Cell RNA Sequencing AnalysisSemantic proximity Read ↗

Unveiling prognostic genes and regulatory mechanisms of exosome in prostate cancer: an integrated analysis of bulk transcriptomics and single-cell RNA sequencing dataSemantic proximity Read ↗

Unmasking Neuroendocrine Prostate Cancer with a Machine Learning-Driven 7-Gene Stemness Signature that Predicts ProgressionSemantic proximity Read ↗

Establishing a Prognostic Model in Prostate Adenocarcinoma through Comprehensive scRNA-Seq and Bulk RNA-Seq Analysis and ValidationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.